Home
Iambic

Iambic Market Share Analysis for August 2026

Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.

Health > Biotechnology and Pharmaceuticals

Domainiambic.ai

Year Founded2019

Employees51 - 200

Annual Revenue$2M - $5M

Iambic

Iambic (including company regionals)

iambic.ai

See more website traffic and engagement information

Iambic Revenue up to August 2026 is 2M - 5M

revenue generated by Iambic top domains

Iambic top domains revenue over 3 years

Revenue for Iambic top domains

iambic.ai2M - 5M

See more with Sales Intelligence

Total visits to Iambic's top domains

Understand Iambic market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

iambic.ai16.9K

See more with Sales Intelligence

Avg. visit duration in Iambic's top domains

Analyze Iambic engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

iambic.ai00:00:36

See more with Sales Intelligence

Avg. pageviews on Iambic's top domains

See how Iambic keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

iambic.ai1.90

See more with Sales Intelligence

Iambic top competitors by domain

Top similar sites in August 2026, ranked by their affinity

seqone.comCompany NameSeqOneEmployees51 - 200HQFrance, MontpellierAnnual revenue$5M - $10MTotal visits11.1KN/A

Top technologies used by Iambic

These are the website technologies, by industry, used by Iambic top domains

Content Management System (3)

Netlify

Business Solutions (1)

DocuSign

Email Services (1)

Microsoft Exchange Online

Mobile (1)

Apple Mobile Tags

More Technologies

1

See all

News & Signals from Iambic

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIambic Therapeutics, Inc. is developing novel medicines using AI on Jul 1st '26.Berlin/Germany - Bayer and Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, recently announced a drug discovery collaboration in which Bayer will discover new medicines using Iambic's AI-driven platform.

NewsBayer AG partnered with Iambic Therapeutics, Inc. on Jul 1st '26.Bayer has entered into a strategic sourcing partnership with science and technology firm Iambic Therapeutics to advance the process of small molecule discovery and development of new drugs.

NewsIambic Therapeutics, Inc. partnered with Takeda Pharmaceuticals on Feb 9th '26.Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced a multi-year technology and discovery collaboration agreement with Takeda that will use Iambic's industry leading AI drug discovery models to advance a select set of high-priority small molecule programs, initially in Takeda's Oncology and Gastrointestinal and Inflammation therapeutic areas.